These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

559 related articles for article (PubMed ID: 38239190)

  • 1. Current trends and future prospects of drug repositioning in gastrointestinal oncology.
    Fatemi N; Karimpour M; Bahrami H; Zali MR; Chaleshi V; Riccio A; Nazemalhosseini-Mojarad E; Totonchi M
    Front Pharmacol; 2023; 14():1329244. PubMed ID: 38239190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repurposing approved non-oncology drugs for cancer therapy: a comprehensive review of mechanisms, efficacy, and clinical prospects.
    Mohi-Ud-Din R; Chawla A; Sharma P; Mir PA; Potoo FH; Reiner Ž; Reiner I; Ateşşahin DA; Sharifi-Rad J; Mir RH; Calina D
    Eur J Med Res; 2023 Sep; 28(1):345. PubMed ID: 37710280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
    Shoaib M; Kamal MA; Rizvi SMD
    Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug repurposing: An emerging strategy in alleviating skin cancer.
    Kumbhar P; Kole K; Yadav T; Bhavar A; Waghmare P; Bhokare R; Manjappa A; Jha NK; Chellappan DK; Shinde S; Singh SK; Dua K; Salawi A; Disouza J; Patravale V
    Eur J Pharmacol; 2022 Jul; 926():175031. PubMed ID: 35580707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug repositioning in cancer: The current situation in Japan.
    Masuda T; Tsuruda Y; Matsumoto Y; Uchida H; Nakayama KI; Mimori K
    Cancer Sci; 2020 Apr; 111(4):1039-1046. PubMed ID: 31957175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug repurposing for viral cancers: A paradigm of machine learning, deep learning, and virtual screening-based approaches.
    Ahmed F; Kang IS; Kim KH; Asif A; Rahim CSA; Samantasinghar A; Memon FH; Choi KH
    J Med Virol; 2023 Apr; 95(4):e28693. PubMed ID: 36946499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug Repurposing Approaches: Existing Leads For Novel Threats And Drug Targets.
    Usha T; Middha SK; Kukanur AA; Shravani RV; Anupama MN; Harshitha N; Rahamath A; Kukanuri SA; Goyal AK
    Curr Protein Pept Sci; 2020 Sep; ():. PubMed ID: 32957901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug Repurposing for Cancer Therapy in the Era of Precision Medicine.
    K W To K; Cho WCS
    Curr Mol Pharmacol; 2022; 15(7):895-903. PubMed ID: 35156588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug Repurposing, an Attractive Strategy in Pancreatic Cancer Treatment: Preclinical and Clinical Updates.
    De Lellis L; Veschi S; Tinari N; Mokini Z; Carradori S; Brocco D; Florio R; Grassadonia A; Cama A
    Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unlocking the synthetic approaches and clinical application of approved small-molecule drugs for gastrointestinal cancer treatment: A comprehensive exploration.
    Li XJ; Nie P; Herdewijn P; Sun JG
    Eur J Med Chem; 2023 Dec; 262():115928. PubMed ID: 37944387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarker-guided repurposing of chemotherapeutic drugs for cancer therapy: a novel strategy in drug development.
    Stenvang J; Kümler I; Nygård SB; Smith DH; Nielsen D; Brünner N; Moreira JM
    Front Oncol; 2013 Dec; 3():313. PubMed ID: 24400218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current Status and Future Perspective of Immunotherapy in Gastrointestinal Cancers.
    Lu Z; Peng Z; Liu C; Wang Z; Wang Y; Jiao X; Li J; Shen L
    Innovation (Camb); 2020 Aug; 1(2):100041. PubMed ID: 34557714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug repurposing-an emerging strategy in cancer therapeutics.
    Turabi KS; Deshmukh A; Paul S; Swami D; Siddiqui S; Kumar U; Naikar S; Devarajan S; Basu S; Paul MK; Aich J
    Naunyn Schmiedebergs Arch Pharmacol; 2022 Oct; 395(10):1139-1158. PubMed ID: 35695911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computer-aided drug repurposing for cancer therapy: Approaches and opportunities to challenge anticancer targets.
    Mottini C; Napolitano F; Li Z; Gao X; Cardone L
    Semin Cancer Biol; 2021 Jan; 68():59-74. PubMed ID: 31562957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the Clinical Use of Levosimendan and Perspectives on its Future in Oncology.
    Ribeiro E; Vale N
    Biomolecules; 2023 Aug; 13(9):. PubMed ID: 37759695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug Repositioning for P-Glycoprotein Mediated Co-Expression Networks in Colorectal Cancer.
    Beklen H; Gulfidan G; Arga KY; Mardinoglu A; Turanli B
    Front Oncol; 2020; 10():1273. PubMed ID: 32903699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticulate drugs and vaccines: Breakthroughs and bottlenecks of repurposing in breast cancer.
    Kumbhar P; Kole K; Khadake V; Marale P; Manjappa A; Nadaf S; Jadhav R; Patil A; Singh SK; Dua K; Jha NK; Disouza J; Patravale V
    J Control Release; 2022 Sep; 349():812-830. PubMed ID: 35914614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug repurposing for COVID-19: Approaches, challenges and promising candidates.
    Ng YL; Salim CK; Chu JJH
    Pharmacol Ther; 2021 Dec; 228():107930. PubMed ID: 34174275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.